Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 16;18(5):sfaf113.
doi: 10.1093/ckj/sfaf113. eCollection 2025 May.

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy

Maxime Teisseyre  1   2   3   4 , Alexandre Destere  5   6 , Marion Cremoni  1   2   3   4 , Sonia Boyer-Suavet  7 , Alexandre Karamé  8 , Léa Corlu  9 , Gabrielle Duneau  10 , Paule Poirier  11 , Siriane Lefevre  9 , Kévin Zorzi  1   2   3 , Céline Fernandez  1   3 , Vesna Brglez  1   3   4 , Sylvia Benzaken  4 , Guillaume Favre  2 , Milou-Daniel Drici  5 , Vincent L M Esnault  1   2 , Sylvain Benito  12 , Barbara Seitz-Polski  1   2   3   4
Affiliations

Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy

Maxime Teisseyre et al. Clin Kidney J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflict of interest.

References

    1. Teisseyre M, Cremoni M, Boyer-Suavet S. et al. Rituximab immunomonitoring predicts remission in membranous nephropathy. Front Immunol 2021;12:738788. 10.3389/fimmu.2021.738788 - DOI - PMC - PubMed
    1. Seitz-Polski B, Dahan K, Debiec H. et al. High-dose rituximab and early remission in PLA2R1-related membranous nephropathy. Clin J Am Soc Nephrol 2019;14:1173–82. 10.2215/CJN.11791018 - DOI - PMC - PubMed
    1. Destere A, Teisseyre M, Merino D. et al. Optimization of rituximab therapy in adult patients with PLA2R1-associated membranous nephropathy with artificial intelligence. Kidney Int Rep 2024;9:134–44. 10.1016/j.ekir.2023.10.023 - DOI - PMC - PubMed
    1. van den Brand JAJG, Ruggenenti P, Chianca A. et al. Safety of rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy. J Am Soc Nephrol 2017;28:2729–37. 10.1681/ASN.2016091022 - DOI - PMC - PubMed

LinkOut - more resources